<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The serrated pathway to <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> formation involves oncogenic mutations in the BRAF gene, which are sufficient for initiation of hyperplastic growth but not for <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>A previous analysis of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> revealed that overexpression of splice variant Rac1b occurs in around 80% of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with mutant BRAF and both events proved to cooperate in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell survival </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we provide evidence for increased expression of Rac1b in patients with inflamed human colonic mucosa as well as following experimentally induced <z:hpo ids='HP_0002583'>colitis</z:hpo> in mice </plain></SENT>
<SENT sid="3" pm="."><plain>The increase of Rac1b in the mouse model was specifically prevented by the <z:chebi fb="2" ids="35475">nonsteroidal anti-inflammatory drug</z:chebi> <z:chebi fb="1" ids="5855">ibuprofen</z:chebi>, which also inhibited Rac1b expression in cultured HT29 <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> cells through a cyclooxygenase inhibition.independent mechanism </plain></SENT>
<SENT sid="4" pm="."><plain>Accordingly, the presence of <z:chebi fb="1" ids="5855">ibuprofen</z:chebi> led to a reduction of HT29 cell survival in vitro and inhibited Rac1b-dependent <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> of HT29 xenografts </plain></SENT>
<SENT sid="5" pm="."><plain>Together, our results suggest that stromal cues, namely, <z:mp ids='MP_0001845'>inflammation</z:mp>, can trigger changes in Rac1b expression in the colon and identify <z:chebi fb="1" ids="5855">ibuprofen</z:chebi> as a highly specific and efficient inhibitor of Rac1b overexpression in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Our data suggest that the use of <z:chebi fb="1" ids="5855">ibuprofen</z:chebi> may be beneficial in the treatment of patients with serrated <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> or with inflammatory colon syndromes </plain></SENT>
</text></document>